Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;145(1):17-23.e1.
doi: 10.3821/1913-701X-145.1.17.

Independent pharmacist prescribing in Canada

Independent pharmacist prescribing in Canada

Michael R Law et al. Can Pharm J (Ott). 2012 Jan.

Abstract

Background: While pharmacists are trained in the selection and management of prescription medicines, traditionally their role in prescribing has been limited. In the past 5 years, many provinces have expanded the pharmacy scope of practice. However, there has been no previous systematic investigation and comparison of these policies.

Methods: We performed a comprehensive policy review and comparison of pharmacist prescribing policies in Canadian provinces in August 2010. Our review focused on documents, regulations and interviews with officials from the relevant government and professional bodies. We focused on policies that allowed community pharmacists to independently continue, adapt (modify) and initiate prescriptions.

Results: Pharmacists could independently prescribe in 7 of 10 provinces, including continuing existing prescriptions (7 provinces), adapting existing prescriptions (4 provinces) and initiating new prescriptions (3 provinces). However, there was significant heterogeneity between provinces in the rules governing each function.

Conclusions: The legislated ability of pharmacists to independently prescribe in a community setting has substantially increased in Canada over the past 5 years and looks poised to expand further in the near future. Moving forward, these programs must be evaluated and compared on issues such as patient outcomes and safety, professional development, human resources and reimbursement.

PubMed Disclaimer

References

    1. Sketris I. Extending prescribing privileges in Canada. Can Pharm J. 2009;142(1):17.
    1. Morgan S, Raymond C, Mooney D, Martin D. The Canadian Rx atlas. Vancouver (BC): Centre for Health Services and Policy Research, University of British Columbia; 2008.
    1. Canadian Institute for Health Information. Health care in Canada, 2008. Ottawa (ON): CIHI; 2008.
    1. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–67. - PubMed
    1. Dragomir A, Côté R, Roy L. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–25. et al. - PubMed